Literature DB >> 21898983

Is fragmented financing bad for your health?

Steven D Pizer1, John A Gardner.   

Abstract

Americans finance health care through a variety of private insurance plans and public programs. This organizational fragmentation could threaten continuity of care and adversely affect outcomes. Using a large sample of veterans who were eligible for mixtures of Veterans Health Administration- and Medicare-financed care, we estimate a system of equations to account for simultaneity in the determination of financing configuration and the probability of hospitalization for an ambulatory care sensitive condition. We find that a change of one standard deviation in financing fragmentation increases the risk of an adverse outcome by one-fifth.

Mesh:

Year:  2011        PMID: 21898983     DOI: 10.5034/inquiryjrnl_48.02.02

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  17 in total

1.  Dual-System Use and Intermediate Health Outcomes among Veterans Enrolled in Medicare Advantage Plans.

Authors:  Alicia L Cooper; Lan Jiang; Jean Yoon; Mary E Charlton; Ira B Wilson; Vincent Mor; Kenneth W Kizer; Amal N Trivedi
Journal:  Health Serv Res       Date:  2015-04-06       Impact factor: 3.402

2.  Duplicate federal payments for dual enrollees in Medicare Advantage plans and the Veterans Affairs health care system.

Authors:  Amal N Trivedi; Regina C Grebla; Lan Jiang; Jean Yoon; Vincent Mor; Kenneth W Kizer
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

3.  Guideline-concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part D.

Authors:  Nicolae Done; Amanda M Roy; Yingzhe Yuan; Steven D Pizer; Adam J Rose; Julia C Prentice
Journal:  Health Serv Res       Date:  2018-11-11       Impact factor: 3.402

4.  Dual Use and Hospital Admissions among Veterans Enrolled in the VA's Homeless Patient Aligned Care Team.

Authors:  Amal N Trivedi; Lan Jiang; Erin E Johnson; Julie C Lima; Michael Flores; Thomas P O'Toole
Journal:  Health Serv Res       Date:  2018-08-27       Impact factor: 3.402

5.  Dual Use of Department of Veterans Affairs and Medicare Benefits on High-Risk Opioid Prescriptions in Veterans Aged 65 Years and Older: Insights from the VA Musculoskeletal Disorders Cohort.

Authors:  Philip W Chui; Lori A Bastian; Eric DeRycke; Cynthia A Brandt; William C Becker; Joseph L Goulet
Journal:  Health Serv Res       Date:  2018-10-08       Impact factor: 3.402

6.  Effect on VA Patient Satisfaction of Provider's Use of an Integrated Viewer of Multiple Electronic Health Records.

Authors:  Aaron Legler; Megan Price; Megha Parikh; Jonathan R Nebeker; Merry C Ward; Linda Wedemeyer; Steven D Pizer
Journal:  J Gen Intern Med       Date:  2018-10-18       Impact factor: 5.128

7.  Attributable Cost of Dementia: Demonstrating Pitfalls of Ignoring Multiple Health Care System Utilization.

Authors:  Lianlian Lei; Susan G Cooley; Ciaran S Phibbs; Bruce Kinosian; Richard M Allman; Anton P Porsteinsson; Orna Intrator
Journal:  Health Serv Res       Date:  2018-09-23       Impact factor: 3.402

8.  Measures of care fragmentation: Mathematical insights from population genetics.

Authors:  Noah A Rosenberg; Donna M Zulman
Journal:  Health Serv Res       Date:  2020-01-22       Impact factor: 3.402

9.  Reasons Older Veterans Use the Veterans Health Administration and Non-VHA Care in an Urban Environment.

Authors:  Matthew R Augustine; Tanieka Mason; Abigail Baim-Lance; Kenneth Boockvar
Journal:  J Am Board Fam Med       Date:  2021 Mar-Apr       Impact factor: 2.395

10.  Effect of Dual Use of Veterans Affairs and Medicare Part D Drug Benefits on Antihypertensive Medication Supply in a National Cohort of Veterans with Dementia.

Authors:  Carolyn T Thorpe; Walid F Gellad; Maria K Mor; John P Cashy; John R Pleis; Courtney H Van Houtven; Loren J Schleiden; Joseph T Hanlon; Joshua D Niznik; Ronald L Carico; Chester B Good; Joshua M Thorpe
Journal:  Health Serv Res       Date:  2018-10-16       Impact factor: 3.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.